Demand for biological drugs is putting pressure on health budgets. Christopher Kelly and Fraz Mir examine why they are so expensive and what can be done to increase access
No takes yet. Share an insight, caveat, or question.
Kelly et al. (2009) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: